Diabetes and Wound Healing

The relationship between diabetes wound healing is one of the most clinically important aspects of diabetes care — and one where the biological consequences of chronic hyperglycemia have the most immediate, tangible impact on daily life and long-term outcomes. Normal wound healing is a precisely orchestrated biological process involving four overlapping phases: hemostasis (stopping bleeding), inflammation (clearing bacteria and debris), proliferation (rebuilding tissue), and remodeling (strengthening the new tissue). In adults with diabetes, hyperglycemia impairs every one of these phases simultaneously — producing wounds that bleed longer, take more time to clear bacteria (increasing infection risk), fill in more slowly with granulation tissue, synthesize lower-quality collagen, and achieve lower final tensile strength. The practical consequences of this impaired diabetes wound healing are visible in every day of clinical practice: the surgical incision that dehisces, the foot ulcer that persists for months despite appropriate treatment, the skin tear that becomes a cellulitis that requires hospitalization. Understanding why wounds heal poorly in diabetes, what accelerates healing, how to recognize early infection, and when to seek emergency care is essential knowledge for every adult with diabetes.

How Diabetes Impairs Wound Healing: Phase by Phase

Understanding exactly how diabetes wound healing is impaired explains why managing each phase of healing requires active attention rather than passive waiting:

• Inflammatory phase impairment — bacterial clearance is delayed: Immediately after a wound occurs, neutrophils and macrophages migrate to the site to kill bacteria and clear cellular debris (phagocytosis). In adults with poorly controlled diabetes, neutrophil chemotaxis (migration toward the wound) is slowed, neutrophil phagocytic capacity is reduced, the oxidative burst (the intracellular killing mechanism using reactive oxygen species) is impaired, and macrophage polarization toward the M1 phenotype (inflammatory, antibacterial) is dysregulated. The result is a wound that is slower to clear bacterial contamination, more susceptible to biofilm formation (which dramatically increases infection resistance), and remains in a prolonged inflammatory state rather than transitioning to the proliferative phase of healing. The prolonged inflammatory state itself further damages the wound bed through excessive proteases (enzymes that break down healing tissue) — a biochemical reason why acute wounds become chronic non-healing wounds in adults with poorly controlled diabetes. The A1C monitoring that tracks the glucose control underlying these immune defects is in our A1C testing schedule guide.
• Proliferative phase impairment — new tissue forms slowly and poorly: The proliferative phase of healing involves fibroblast migration into the wound, collagen synthesis (which forms the structural scaffold of new tissue), and angiogenesis (formation of new blood vessels to supply the healing wound with oxygen and nutrients). In adults with diabetes, all three of these processes are impaired: fibroblast migration and proliferation are reduced; collagen synthesis is impaired (through both reduced fibroblast activity and glycation of existing collagen, which interferes with normal collagen organization); and angiogenesis is severely impaired — because endothelial cell migration and VEGF (vascular endothelial growth factor) signaling are both reduced in chronic hyperglycemia. Impaired angiogenesis means that healing tissue receives less oxygen — and wound healing requires substantial oxygen for collagen cross-linking, oxidative bacterial killing, and cellular energy. The compounding effect of peripheral arterial disease (common in adults with diabetes) on top of impaired angiogenesis produces the ischemic wound that cannot heal regardless of optimal wound care. The neuropathy context that explains the structural contribution to wound healing impairment is in our diabetic neuropathy: symptoms and prevention guide.
• Remodeling phase impairment — weaker scar tissue: The final phase of wound healing involves remodeling — conversion of type III collagen (laid down rapidly during proliferation) to type I collagen (stronger, more organized), cross-linking of collagen fibers under the influence of enzymes including lysyl oxidase, and gradual reduction of wound vascularity. In adults with diabetes, this remodeling process produces collagen with abnormal cross-linking, reduced tensile strength (the healed wound tears more easily under stress), and impaired elasticity. This explains why healed surgical incisions and healed ulcers in adults with diabetes are more susceptible to re-injury than healed wounds in adults without diabetes — the wound may appear to have closed, but the tissue beneath is structurally weaker. The foot protection strategies that reduce re-injury risk are in our diabetic foot problems: prevention and care guide. The broader diabetes complications context is in our diabetes complications: what adults should know guide.

Recognizing Wound Infection: Early Warning Signs in Adults With Diabetes

Wound infection in adults with diabetes wound healing challenges is a medical emergency that requires prompt evaluation — because the biological conditions in diabetes (impaired neutrophil function, biofilm susceptibility, ischemia) allow superficial wound infections to progress to deep tissue infection, osteomyelitis, or necrotizing fasciitis within days. The following warning signs require same-day medical evaluation:

• Local signs of wound infection — what to see around the wound: The classic local signs of wound infection are: increased redness (erythema) spreading beyond the immediate wound edge; warmth of the tissue surrounding the wound; swelling (edema) around the wound; purulent (pus-containing) discharge from the wound; odor (particularly the sweet smell of anaerobic infection, or the distinctive odor of Pseudomonas); and increasing pain or tenderness around the wound (though neuropathy may eliminate pain even with significant infection). In neuropathic feet, the absence of pain does not exclude infection — any of the other local signs are sufficient to warrant evaluation. The red streaking of lymphangitis (infection spreading along lymphatic vessels, appearing as red lines extending from the wound) is a sign that infection is spreading systemically and requires urgent evaluation.
• Systemic signs of wound infection — when infection has spread beyond the wound: Systemic signs indicating that wound infection has entered the bloodstream or soft tissues include: fever above 38°C (100.4°F); chills; rapid heart rate; significantly elevated blood glucose (infection-induced stress hyperglycemia often drives blood glucose above 250–300 mg/dL in adults who are normally well-controlled); confusion or unusual fatigue; and hypotension (low blood pressure, suggesting sepsis). Any adult with diabetes who has a wound and develops systemic signs should seek emergency evaluation immediately — sepsis originating from a wound infection in an adult with diabetes can progress to septic shock within hours.
• Signs of osteomyelitis — bone infection that requires specialized evaluation: Osteomyelitis (bone infection underlying a wound or ulcer) should be suspected when: the wound extends deep enough to probe to bone (the probe-to-bone test — a blunt sterile probe inserted into the wound that contacts hard bone — is a simple bedside test with high positive predictive value for osteomyelitis in the right clinical context); the wound has been present for more than 4–6 weeks despite appropriate treatment without significant healing; X-ray shows bone destruction or periosteal reaction around the wound; or MRI (the gold standard for osteomyelitis diagnosis) shows bone marrow edema or cortical destruction. Osteomyelitis requires prolonged antibiotic therapy (6–12 weeks), often with surgical debridement or partial bone resection, and should be managed by a multidisciplinary team including infectious disease specialists and orthopedics or podiatric surgery. The infections guide with the broader context of infection management in diabetes is our diabetes and infections article. The foot problems guide covering the wound care and emergency evaluation protocol is our diabetic foot problems: prevention and care guide. The NIDDK’s wound healing and foot problems guidance, the ADA’s wound and foot complication resources, and the CDC’s diabetes wound care information provide authoritative clinical information on wound healing and infection management in adults with diabetes.

Supporting Wound Healing in Diabetes: What You Can Do

Adults with diabetes wound healing challenges can take several concrete, evidence-based actions to improve healing outcomes — both for acute wounds and for chronic non-healing wounds:

• Optimize blood glucose control during the healing period: Blood glucose control is the single most impactful factor under the patient’s direct control for improving wound healing. Acute hyperglycemia (blood glucose above 200 mg/dL) acutely impairs neutrophil function and angiogenesis within hours; chronic hyperglycemia accumulates structural damage that makes healing progressively more difficult. Working with a diabetes care provider to intensify glucose management during any healing period — whether through medication adjustment, dietary modification, or increased activity — directly improves healing rates. Target blood glucose during wound healing: most clinicians aim for blood glucose below 180 mg/dL (with fasting levels below 130 mg/dL) during active wound healing, as these targets are achievable without significant hypoglycemia risk while providing meaningful immunological benefit. The A1C testing guide is our A1C testing schedule guide.
• Proper wound cleansing and moist wound care: Clean wounds heal faster than dirty wounds, and moist wound environments heal faster than dry wound environments. Gently clean acute wounds with normal saline or mild soap and water — avoid povidone-iodine (Betadine), hydrogen peroxide, or bleach solutions directly in the wound, as these agents damage fibroblasts and keratinocytes and impair healing. After cleaning, apply a moisture-retaining dressing (hydrocolloid, foam, or non-adherent silicone dressing) that maintains a moist environment without becoming macerated (too wet). Dry scabs in fact delay re-epithelialization (skin closure) by forcing keratinocytes to migrate under the scab rather than directly across a moist wound surface. Do not use occlusive dressings on infected wounds — these trap bacteria. The foot wound care principles that apply to all diabetic skin wounds are in our diabetic foot problems: prevention and care guide.
• Nutrition for wound healing — protein, vitamins, and micronutrients: Wound healing is metabolically demanding — it requires adequate protein (for collagen synthesis and immune cell production), zinc (for fibroblast function and DNA synthesis), vitamin C (an essential cofactor for collagen cross-linking by proline hydroxylase), and vitamin A (for epithelialization and macrophage function). Malnutrition — which is underrecognized in adults with Type 2 diabetes, who may be overweight while being micronutrient deficient — significantly impairs wound healing. Adults with poorly healing wounds should be assessed for nutritional status, and protein intake should be optimized to 1.2–1.5 grams per kilogram of body weight per day during wound healing. Oral nutritional supplements specifically formulated for wound healing (high protein, with zinc, vitamin C, and arginine — a precursor to nitric oxide that promotes vasodilation and wound healing) are beneficial for adults with wounds and documented nutritional deficiency or inadequate oral intake.
• Pressure offloading and positioning — preventing further wound damage: For wounds on pressure-bearing areas (heels, sacrum, malleoli from hospital immobility; plantar foot from weight-bearing in neuropathic ulcers), offloading the pressure from the wound surface is essential for healing. Total contact casting is the gold standard for plantar diabetic foot ulcers. Hospital-acquired pressure injuries in adults with diabetes should be prevented through regular repositioning, specialty foam or air mattresses, and heel protectors. Any wound on a pressure-bearing surface in an adult with diabetes that is not actively offloaded will not heal regardless of other wound care interventions. The kidney health monitoring that provides the full metabolic context for wound healing is in our eGFR and kidney function in diabetes guide. The annual monitoring checklist that coordinates diabetes wound care with all other diabetes care is in our annual diabetes care checklist. The NIDDK’s wound healing information, the ADA’s wound care resources, and the CDC’s diabetes complication prevention provide authoritative guidance on wound healing support in adults with diabetes.

Advanced Wound Care Treatments for Non-Healing Diabetic Wounds

When standard wound care (cleaning, dressing, offloading, and glucose optimization) does not produce expected healing progress — typically defined as less than 50% wound area reduction in 4 weeks for a wound treated with appropriate standard care — advanced wound therapies can be considered. These treatments address specific mechanisms of impaired diabetes wound healing and have evidence supporting their use in chronic non-healing wounds:

• Negative pressure wound therapy (NPWT) — vacuum-assisted closure: NPWT uses a foam dressing placed in the wound connected to a vacuum pump through sealed tubing, applying continuous or intermittent negative pressure (typically -75 to -125 mmHg) to the wound surface. The mechanisms of benefit are multiple: negative pressure removes wound exudate (including bacteria-laden fluid and inflammatory mediators that inhibit healing), mechanically deforms wound cells in a way that stimulates proliferation (mechanotransduction), promotes angiogenesis, draws wound edges together, and reduces wound edema. NPWT is particularly useful for large or deep wounds following surgical debridement of infected diabetic foot wounds, post-amputation wounds, and wounds with significant undermining. It reduces wound volume rapidly and is associated with faster granulation tissue formation compared with standard moist wound care in multiple randomized trials of diabetic foot wounds.
• Bioengineered skin substitutes and growth factor treatments: Several advanced biological treatments target the specific growth factor deficiencies and cellular dysfunction of chronic diabetic wounds. Becaplermin (Regranex) — a topical recombinant PDGF-BB (platelet-derived growth factor) gel — is FDA-approved for neuropathic diabetic foot ulcers and has demonstrated significantly improved healing rates in randomized trials compared with placebo. Bioengineered skin substitutes (Apligraf — a bilayered living skin construct containing keratinocytes and fibroblasts; Dermagraft — a dermal substitute; Grafix — a cryopreserved placental membrane) provide both structural scaffolding and growth factor delivery to chronic wounds that have failed standard care. These advanced therapies are reserved for wounds that have been properly offloaded, debrided, and treated for infection without healing progress — they are adjuncts to, not substitutes for, the foundational wound care principles.
• Hyperbaric oxygen therapy (HBOT) for ischemic diabetic wounds: Hyperbaric oxygen therapy — in which the patient breathes 100% oxygen at 2–3 times atmospheric pressure in a pressurized chamber — dramatically increases oxygen delivery to ischemic wound tissues. At 2.4 atmospheres breathing 100% oxygen, plasma-dissolved oxygen rises from approximately 0.3 mL/dL (at normal atmospheric pressure) to approximately 6 mL/dL — enough to support wound healing even in the absence of red blood cell oxygen delivery in severely ischemic tissue. HBOT also stimulates angiogenesis (through hypoxia-inducible factor pathways), promotes neutrophil oxidative killing, and suppresses bacterial growth in the wound environment. HBOT is used for Wagner grade 3 or higher diabetic foot wounds (wounds with deep abscess or osteomyelitis) that have failed standard therapy and have evidence of salvageable ischemic tissue on transcutaneous oxygen measurement. It requires daily sessions (typically 30–40 sessions of 90 minutes each) in a specialized facility and is covered by Medicare for qualifying diabetic lower-extremity wounds. The diabetes retinopathy guide that covers another major microvascular complication alongside wound healing impairment is our diabetic retinopathy: what to know article. The annual monitoring checklist that coordinates wound care with all other diabetes care components is in our annual diabetes care checklist. The NIDDK’s wound healing resources, the ADA’s foot complication guidance, and the CDC’s diabetes complication prevention information provide authoritative clinical guidance on advanced wound care in adults with diabetes.

The Role of Smoking Cessation and Blood Pressure Control in Wound Healing

Two modifiable factors beyond blood glucose significantly impair diabetes wound healing and deserve special attention when any wound is being managed: smoking and uncontrolled blood pressure.

Smoking causes direct vasoconstriction of wound-bed microvasculature, reducing tissue oxygen delivery to levels that can prevent healing of even well-managed wounds. Nicotine stimulates thromboxane A2 production (causing platelet aggregation and vasoconstriction) and reduces prostacyclin (normally vasodilatory and anti-platelet). Carbon monoxide from cigarette smoke binds hemoglobin with 200 times the affinity of oxygen, reducing oxygen-carrying capacity. These combined effects make smoking one of the most potent impairers of wound healing known — smokers with diabetes who continue to smoke during wound healing have dramatically worse healing outcomes than non-smokers with diabetes. Smoking cessation produces measurable improvements in wound-bed perfusion within weeks of stopping, and even short-term preoperative cessation (4–8 weeks before elective surgery) significantly reduces surgical wound complication rates.

Uncontrolled hypertension accelerates atherosclerosis in the small vessels supplying wound tissue, reducing capillary density and oxygen delivery. Blood pressure control below 130/80 mmHg (the ADA target for adults with diabetes and cardiovascular risk) directly supports wound healing by maintaining microvascular blood supply. The blood pressure monitoring that tracks this key wound healing factor is in our blood pressure monitoring in diabetes guide. The diabetes and infections guide that covers the infection complications of impaired wound healing is our diabetes and infections article. The diabetes emergency guide covering when wound complications become emergencies is our when diabetes symptoms become an emergency article. The NIDDK’s foot problems and wound healing, the ADA’s foot complication and wound care guide, and the CDC’s diabetes wound care resources provide authoritative information on improving wound healing outcomes in adults with diabetes.

Adults with diabetes who address wound healing comprehensively — optimizing blood glucose, blood pressure, and nutrition; eliminating smoking; following proper wound care technique; offloading pressure wounds; and seeking early medical evaluation when infection signs appear — achieve significantly better healing outcomes than adults who manage glucose alone without addressing these other healing-critical factors. Every wound in an adult with diabetes deserves to be taken seriously from day one — because the biological conditions of diabetes mean that the window from minor skin break to serious deep infection is shorter than in any other patient population. The kidney disease guide covering another major complication of chronic hyperglycemia alongside wound healing impairment is our diabetic kidney disease: early warning signs article.

Sources: ADA — Standards of Medical Care in Diabetes, wound healing and foot complication management; NIDDK — foot problems and wound healing in diabetes; CDC — diabetes wound care guidance; International Working Group on the Diabetic Foot (IWGDF) — wound healing impairment in diabetes, infection classification, and management guidelines; normal wound healing phases — hemostasis, inflammation, proliferation, remodeling; neutrophil dysfunction in hyperglycemia — impaired chemotaxis, phagocytosis, and oxidative burst; fibroblast dysfunction in chronic hyperglycemia — reduced migration, proliferation, and collagen synthesis; angiogenesis impairment in diabetes — reduced VEGF signaling and endothelial migration; glycated collagen abnormalities — reduced cross-linking, tensile strength, and elasticity in diabetic wounds; biofilm formation in chronic diabetic wounds — resistance to antibiotics and immune clearance; probe-to-bone test for osteomyelitis sensitivity and specificity; MRI as gold standard for osteomyelitis diagnosis in diabetic foot; surgical site infection rates in adults with diabetes — two to three times general population; preoperative glycemic control and surgical site infection reduction; diabetic foot ulcer epidemiology — 25% lifetime prevalence, 6–14 week healing time, 20% amputation rate; necrotizing fasciitis in diabetes — clinical recognition and surgical emergency management.